CVGRX
Price
$37.70
Change
-$0.13 (-0.34%)
Updated
Apr 17 closing price
Net Assets
1.33B
VIGRX
Price
$181.21
Change
+$0.19 (+0.10%)
Updated
Apr 17 closing price
Net Assets
260.76B
Ad is loading...

CVGRX vs VIGRX

Header iconCVGRX vs VIGRX Comparison
Open Charts CVGRX vs VIGRXBanner chart's image
Calamos Growth A
Price$37.70
Change-$0.13 (-0.34%)
VolumeN/A
Net Assets1.33B
Vanguard Growth Index Investor
Price$181.21
Change+$0.19 (+0.10%)
VolumeN/A
Net Assets260.76B
CVGRX vs VIGRX Comparison Chart
Loading...
View a ticker or compare two or three
VS
CVGRX vs. VIGRX commentary
Apr 19, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CVGRX is a Buy and VIGRX is a Buy.

Ad is loading...
FUNDAMENTALS
Fundamentals
VIGRX has more cash in the bank: 261B vs. CVGRX (1.33B). VIGRX pays higher dividends than CVGRX: VIGRX (0.39) vs CVGRX (0.00). CVGRX was incepted earlier than VIGRX: CVGRX (35 years) vs VIGRX (32 years). CVGRX (1.29) is less costly to investors than VIGRX (0.17). CVGRX is a more actively managed with annual turnover of: 42.00 vs. VIGRX (5.00). CVGRX has a lower initial minimum investment than VIGRX: CVGRX (2500) vs VIGRX (3000). VIGRX annual gain was more profitable for investors over the last year : 6.13 vs. CVGRX (-2.71). VIGRX return over 5 years is better than : 99.42 vs. CVGRX (34.02).
CVGRXVIGRXCVGRX / VIGRX
Total Expense Ratio1.290.17759%
Annual Report Gross Expense Ratio1.290.17759%
Fund Existence35 years32 years-
Gain YTD-14.975-14.236105%
Front Load5%N/A-
Min. Initial Investment2500300083%
Min. Initial Investment IRAN/AN/A-
Net Assets1.33B261B1%
Annual Yield % from dividends0.000.39-
Returns for 1 year-2.716.13-44%
Returns for 3 years10.1430.4633%
Returns for 5 years34.0299.4234%
Returns for 10 years-12.59224.18-6%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
RCKT6.330.18
+2.93%
Rocket Pharmaceuticals
OVV33.820.72
+2.18%
Ovintiv
USAC25.220.31
+1.24%
USA Compression Partners LP
UNB31.340.35
+1.13%
Union Bankshares
VVOS2.100.02
+0.96%
Vivos Therapeutics